2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow SPI-2012: new trials by email Literature Review of SPI-2012 trials Research Report on SPI-2012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide SPI-2012, Pegfilgrastim, Docetaxel - Neutropenia, Breast Cancer | Phase 3 | Completed | Spectrum Pharmaceuticals, Inc | 237 | 2017-05-10 | 2022-03-02 |
| SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) SPI-2012, Pegfilgrastim, Docetaxel - Neutropenia, Breast Cancer | Phase 3 | Completed | Spectrum Pharmaceuticals, Inc | 406 | 2016-01-19 | 2022-03-02 |
Breast Neoplasms (2) · Neutropenia (2)
Spectrum Pharmaceuticals, Inc (2)
Canada (2) · South Korea (2) · United States (2) · Hungary (1) · India (1) · Poland (1)
2016 (1)